The National Institutes of Health (NIH) launched the Trial Innovation Network (TIN) in 2017 to help researchers carry out multicenter clinical trials better, faster and more cost-efficiently, and to create a national laboratory to study, understand and innovate the...

In April 2nd, at the peak of the COVID-19 surge, the Mount Sinai Health System (MSHS) announced the launch of an unprecedented biobanking effort to combat COVID-19. The goal was to rapidly collect blood samples from hundreds of COVID-19 patients admitted to MSHS to...

In February of 2020, Turner S. Baker, Ph.D. Candidate and Project Manager at Sinai BioDesign and Dr. Christopher Kellner, Assistant Professor and Director of the Intracerebral Hemorrhage Program were chosen from a highly competitive pool of applicants to participate...

The mission of the ISMMS CTSA, ConduITS, is to streamline and centralize the infrastructure needed to accelerate translational research across an ever expanding research enterprise; foster team science responsive to emerging theories, technologies, and data science...

Early in the COVID-19 pandemic, interdisciplinary teams at Mount Sinai and Rensselaer Polytechnic Institute (RPI) collaborated on two COVID critical needs projects with funding from the CTSA. The teams of scientists at Mount Sinai and RPI with complementary expertise...